We are live on
!
Find out more
Marshall Wace Portfolio holdings
AUM
$127B
1-Year Est. Return
46.06%
This Fund
S&P 500
This Quarter
Est. Return
+26.15%
1 Year Est. Return
+46.06%
3 Year Est. Return
+142.12%
5 Year Est. Return
+190.33%
10 Year Est. Return
+787.47%
AUM
$127B
AUM Growth
+$26.3B
(+26%)
Cap. Flow
+$9.28B
Cap. Flow
% of AUM
7.32%
Top 10 Holdings %
Top 10 Hldgs %
37.66%
Holding
3,898
New
771
Increased
1,083
Reduced
1,182
Closed
795
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares Core S&P 500 ETF
IVV
|
+$9.86B |
| 2 |
Costco
COST
|
+$907M |
| 3 |
AbbVie
ABBV
|
+$643M |
| 4 |
JPMorgan Chase
JPM
|
+$609M |
| 5 |
Bank of America
BAC
|
+$567M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
NVIDIA
NVDA
|
+$1.03B |
| 2 |
Mercado Libre
MELI
|
+$528M |
| 3 |
Broadcom
AVGO
|
+$514M |
| 4 |
SNDK
Sandisk
SNDK
|
+$507M |
| 5 |
Marvell Technology
MRVL
|
+$499M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 34.91% |
| 2 | Technology | 20.64% |
| 3 | Consumer Discretionary | 9.1% |
| 4 | Healthcare | 8.21% |
| 5 | Financials | 7.4% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1526
LeMaitre Vascular
LMAT
$1.82B
| $3.59M | ﹤0.01% |
37,402
-93,818
| -71% | -$9.62M |
|
1527
Kirby Corp
KEX
$7.29B
| $3.57M | ﹤0.01% |
26,261
+23,461
| +838% | +$3.36M |
|
1528
Lifeway Foods
LWAY
$377M
| $3.55M | ﹤0.01% |
118,944
-13,313
| -10% | -$339K |
|
|
NFGC
1529
New Found Gold
NFGC
$688M
| $3.54M | ﹤0.01% |
2,296,568
-140,438
| -6% | -$269K |
|
1530
Smith & Wesson
SWBI
$593M
| $3.53M | ﹤0.01% |
235,008
+5,253
| +2% | +$78.9K |
|
1531
VanEck Semiconductor ETF
SMH
$69.8B
| $3.52M | ﹤0.01% |
5,371
-171,386
| -97% | -$93.5M |
|
1532
Vericel Corp
VCEL
$2B
| $3.51M | ﹤0.01% |
78,796
-127,873
| -62% | -$4.6M |
|
1533
Cactus
WHD
$4.85B
| $3.5M | ﹤0.01% |
68,317
+61,017
| +836% | +$3.4M |
|
1534
US Global Jets ETF
JETS
$727M
| $3.5M | ﹤0.01% |
+105,266
| New | +$2.91M |
|
1535
SAP
SAP
$244B
| $3.49M | ﹤0.01% |
22,620
-174,771
| -89% | -$29.8M |
|
1536
iShares MSCI Emerging Markets ex China ETF
EMXC
$25.8B
| $3.46M | ﹤0.01% |
33,813
-433,244
| -93% | -$40.9M |
|
|
SVC
1537
Service Properties Trust
SVC
$955M
| $3.44M | ﹤0.01% |
407,406
+377,567
| +1,265% | +$2.97M |
|
1538
Marqeta
MQ
$1.69B
| $3.43M | ﹤0.01% |
211,201
-230,552
| -52% | -$3.75M |
|
1539
Choiceone Financial
COFS
$506M
| $3.43M | ﹤0.01% |
100,803
+15,704
| +18% | +$488K |
|
1540
Annovis Bio
ANVS
$55.4M
| $3.43M | ﹤0.01% |
1,842,339
+654,840
| +55% | +$1.27M |
|
1541
Dover
DOV
$26.2B
| $3.42M | ﹤0.01% |
15,258
+10,858
| +247% | +$2.37M |
|
1542
The Mosaic Company
MOS
$8.43B
| $3.42M | ﹤0.01% |
161,352
-1,924,817
| -92% | -$44.5M |
|
|
EFC
1543
Ellington Financial
EFC
$1.72B
| $3.42M | ﹤0.01% |
251,024
+235,255
| +1,492% | +$3.11M |
|
1544
Hecla Mining
HL
$13.7B
| $3.41M | ﹤0.01% |
221,239
+172,950
| +358% | +$3.04M |
|
1545
Albertsons Companies
ACI
$5.89B
| $3.4M | ﹤0.01% |
+251,159
| New | +$4.02M |
|
1546
CALL
Corning
GLW
$143B
| $3.4M | ﹤0.01% |
+13,300
| New | +$2.42M |
|
1547
ImmunityBio
IBRX
$8.79B
| $3.4M | ﹤0.01% |
387,700
+310,675
| +403% | +$2.35M |
|
1548
FTI Consulting
FCN
$4.17B
| $3.39M | ﹤0.01% |
+22,749
| New | +$3.72M |
|
1549
Saic
SAIC
$5.34B
| $3.39M | ﹤0.01% |
30,696
-3,389
| -10% | -$343K |
|
|
BCYC
1550
Bicycle Therapeutics
BCYC
$293M
| $3.38M | ﹤0.01% |
797,940
+420,605
| +111% | +$1.93M |
|
Similar funds
Marshall Wace's Q2 2026 Portfolio in Review
As of Q2 2026, Marshall Wace held 3,898 positions worth $127B, up 26% from $100B the previous quarter. Its ten largest holdings account for 38% of the portfolio.
Marshall Wace deployed $9.28B of net new capital in Q2 2026, opening 771 new positions and adding to 1,083 existing holdings. Its largest new stake was LPL Financial: 975,627 shares worth $275M.
By sector, the portfolio is most concentrated in Miscellaneous at 35% of assets, up from 30% a quarter earlier, followed by Technology and Consumer Discretionary.
On the sell side, the largest reduction was NVIDIA, an estimated $1.03B trimmed.
- Marshall Wace's largest Q2 2026 buy was LPL Financial: 975,627 shares worth $275M.
- Marshall Wace added most to iShares Core S&P 500 ETF in Q2 2026, an estimated $9.86B increase.
- Marshall Wace's biggest Q2 2026 reduction was NVIDIA, cutting an estimated $1.03B.
- Marshall Wace fully exited Merck in Q2 2026, selling an estimated $325M.
- Marshall Wace's ten largest holdings make up 38% of its $127B portfolio in Q2 2026.
- Marshall Wace opened 771 new positions and closed 795 in Q2 2026.
- Marshall Wace's portfolio value rose 26% quarter-over-quarter to $127B.
Based on Marshall Wace's 13F filing for Q2 2026, filed 13 Aug 2026.